Overcoming Clinical Trial Outsourcing Challenges in Latin America Panel Scheduled

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) June 12, 2009 -- (Orange County, California) - Translation company Global Language Solutions, Inc. (GLS) announces its president, Inna Kassatkina, as a panel participant for “The Good, the Bad and the Surmountable: Overcoming Outsourcing Challenges in Latin America” at DIA’s 45th Annual Meeting in San Diego, CA. Kassatkina will address the regulatory, cultural, and logistical differences between clinical research in the U.S. and Latin America.

Other topics covered during the session include the key criteria to identifying a strong outsourcing partner with established relationships in Latin America, communications flow, and liability and requisite documentation. Kassatkina will join Lynn Sutton of ReSearch Pharmaceutical Services, Inc. (RPS) and Karole Sutherland of Sutherland Consulting Group on the panel.

“A major advantage in conducting clinical trials in Latin America is the commonality of Spanish as an official language across the majority of the region. Compared with running a clinical trial across multiple countries in Europe, this can save sponsors significant translation costs and streamline the project timings. Additionally, the commercial markets are quite attractive with relatively lower costs; but this does not come without its challenges. This session addresses these challenges, as well as the need for culturally and linguistically accurate language services,” comments Kassatkina.

The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. This year's program offers learning opportunities for everyone and features the biggest names from industry, regulatory, and academia.

Kassatkina’s session is scheduled for Wednesday, June 24th at 8:30 AM. GLS will also participate as an exhibitor at Booth 231. Visit www.globallanguages.com for more information.

# # #

About the Drug Information Association (DIA)

DIA serves more than 30,000 biopharmaceutical professionals from industry, academia, and regulatory agencies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. For more information, visit www.diahome.org or call +1-215-442-6100.

About Global Language Solutions®:

Global Language Solutions® (GLS) is a full-service ISO 9001 certified translation company delivering solutions in over 100 languages to increase its clients' multicultural and international market share. GLS provides culturally and linguistically accurate document translations, linguistic validation, website localization, multilingual typesetting/graphic design, conference interpreting, voice-overs, and more. The company's clients include leaders in the pharmaceutical, medical devices, healthcare, financial, legal, manufacturing, marketing, and technology industries. GLS is a WBENC-certified Women’s Business Enterprise (WBE) based in Orange County, California. For more information, visit www.globallanguages.com or call +1-949-798-1400.

More information can be found online at http://www.globallanguages.com

     CLINICAL TRIALS     drug information association     Global Language Solutions     Pharmaceutical     research